Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Composur, a Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder

NCT05067478 is registered in ClinicalTrials.gov with Urovant Sciences GmbH as lead sponsor.

NCT NCT05067478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Composur, a Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder
Lead sponsor
Urovant Sciences GmbH
Phase
Observational
Overall status
Completed
Start date
October 28, 2021
Completion date
July 26, 2024
Enrollment
403 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder